No evidence for heterozygote advantage at MTHFR in patients with lumbosacral myelomeningocele or their relatives

Genet Med. 2004 Jan-Feb;6(1):69-70. doi: 10.1097/01.gim.0000106162.27561.68.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Female
  • Genotype
  • Heterozygote
  • Humans
  • Lumbosacral Region / pathology
  • Male
  • Meningomyelocele / genetics*
  • Meningomyelocele / pathology
  • Methylenetetrahydrofolate Dehydrogenase (NAD+) / genetics*
  • Neural Tube Defects / genetics*
  • Neural Tube Defects / pathology
  • Pedigree
  • Point Mutation
  • Sex Factors

Substances

  • Methylenetetrahydrofolate Dehydrogenase (NAD+)